Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide for Refractory Cough in IPF
NCT01135199Phase 2Withdrawn
- Sponsor
- Stanford University
- Start
- Apr 2010
- Primary completion
- Jun 2010
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in idiopathic pulmonary fibrosis (IPF), sponsored by Stanford University. Planned start Apr 2010; status: withdrawn.
02
Drugs
pomalidomide
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT01135199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01135199.